Original article
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials
Mohamed Abdallaha, Landon Brownb, John Provenzab, Raseen Tariqc, Smitha Gowdaa, Ashwani K. Singala,d,
Corresponding author
a Department of Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, SD, United States
b Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States
c Department of Medicine, University of Rochester, NY, United States
d Division of Transplant Hepatology, Avera Transplant Institute, Sioux Falls, SD, United States
Read
4442
Timeswas read the article
2171
Total PDF
2271
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 56 | 148 | 204 |
| 2025 11 | 325 | 896 | 1221 |
| 2025 10 | 84 | 266 | 350 |
| 2025 9 | 117 | 190 | 307 |
| 2025 8 | 141 | 64 | 205 |
| 2025 7 | 239 | 68 | 307 |
| 2025 6 | 93 | 21 | 114 |
| 2025 5 | 110 | 32 | 142 |
| 2025 4 | 98 | 31 | 129 |
| 2025 3 | 94 | 22 | 116 |
| 2025 2 | 67 | 11 | 78 |
| 2025 1 | 37 | 9 | 46 |
| 2024 12 | 27 | 9 | 36 |
| 2024 11 | 33 | 14 | 47 |
| 2024 10 | 21 | 4 | 25 |
| 2024 9 | 33 | 8 | 41 |
| 2024 8 | 39 | 13 | 52 |
| 2024 7 | 23 | 7 | 30 |
| 2024 6 | 22 | 12 | 34 |
| 2024 5 | 32 | 8 | 40 |
| 2024 4 | 32 | 5 | 37 |
| 2024 3 | 55 | 16 | 71 |
| 2024 2 | 100 | 17 | 117 |
| 2024 1 | 86 | 22 | 108 |
| 2023 12 | 38 | 8 | 46 |
| 2023 11 | 39 | 15 | 54 |
| 2023 10 | 31 | 22 | 53 |
| 2023 9 | 29 | 24 | 53 |
| 2023 8 | 16 | 13 | 29 |
| 2023 7 | 16 | 8 | 24 |
| 2023 6 | 15 | 9 | 24 |
| 2023 5 | 26 | 12 | 38 |
| 2023 4 | 20 | 57 | 77 |
| 2023 3 | 12 | 8 | 20 |
| 2023 2 | 9 | 11 | 20 |
| 2023 1 | 12 | 8 | 20 |
| 2022 12 | 19 | 8 | 27 |
| 2022 11 | 25 | 14 | 39 |
| 2022 10 | 0 | 11 | 11 |
| 2022 9 | 0 | 25 | 25 |
| 2022 8 | 0 | 16 | 16 |
| 2022 7 | 0 | 9 | 9 |
Show all
